Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Swartz

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Asian Journal of Andrology|June 26, 2007
Extracellular quality control in the epididymisGail A Cornwall, H Henning von Horsten, Douglas Swartz, et al.
Brachytherapy|October 16, 2012
Long-term outcomes and prognostic factors in patients treated with intraoperatively planned prostate brachytherapyCarlos Vargas, Douglas Swartz, Apoorva Vashi, et al.
Brachytherapy|December 4, 2013
Salvage brachytherapy for recurrent prostate cancerCarlos Vargas, Douglas Swartz, Apoorva Vashi, et al.
Cancer Treatment and Research Communications|February 18, 2019
Initial results of a randomized phase III trial of high dose image guided radiation with or without androgen deprivation therapy for intermediate-risk prostate cancerCarlos E Vargas, Now Bahar Alam, Mitchell Terk, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Asian Journal of Andrology|June 26, 2007
Extracellular quality control in the epididymisGail A Cornwall, H Henning von Horsten, Douglas Swartz, et al.
Brachytherapy|October 16, 2012
Long-term outcomes and prognostic factors in patients treated with intraoperatively planned prostate brachytherapyCarlos Vargas, Douglas Swartz, Apoorva Vashi, et al.
Brachytherapy|December 4, 2013
Salvage brachytherapy for recurrent prostate cancerCarlos Vargas, Douglas Swartz, Apoorva Vashi, et al.
Cancer Treatment and Research Communications|February 18, 2019
Initial results of a randomized phase III trial of high dose image guided radiation with or without androgen deprivation therapy for intermediate-risk prostate cancerCarlos E Vargas, Now Bahar Alam, Mitchell Terk, et al.
Pageof 1